SNDL Acquires Remaining Minority Interest in Nova Cannabis
October 21, 2024
SNDL Inc. completed the previously announced plan of arrangement under which it acquired all of the remaining issued and outstanding shares of Nova Cannabis Inc. that it did not already own, representing about 34.8% of Nova. Under the deal, Nova shareholders received $1.75 per Nova share in cash, with an option to receive SNDL shares in lieu of cash for up to half of the aggregate consideration.
- Buyers
- SNDL Inc.
- Targets
- Nova Cannabis Inc.
- Industry
- Consumer Products
- Location
- Alberta, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SNDL Inc. Acquires The Valens Company
January 17, 2023
Consumer Products
SNDL Inc. completed the previously disclosed acquisition of The Valens Company Inc. in an all‑stock transaction valued at approximately CAD 138 million (plus assumption of a CAD 60 million term loan), issuing ~27.6 million SNDL shares to former Valens shareholders. The deal brings Valens' extraction, processing, manufacturing and lab capabilities into SNDL's vertically integrated cannabis platform and is expected to deliver cost synergies and expand SNDL's branded product offering and low‑cost manufacturing capacity.
-
SNDL Acquires Indiva’s Cannabis Edibles Business and Assets
November 4, 2024
Healthcare Services
SNDL Inc. has successfully closed the acquisition of Indiva Limited’s business and assets under Indiva’s CCAA proceedings. The deal includes Indiva’s 40,000-square-foot cannabis edibles production facility in London, Ontario, along with a portfolio of brands and SKUs intended to expand SNDL’s position in the infused edibles category.
-
Sundial Growers Acquires Alcanna Inc.
October 7, 2021
Retail
Sundial Growers Inc. agreed to acquire all outstanding shares of Alcanna Inc. in an all-stock plan of arrangement valued at approximately C$346 million, giving Alcanna shareholders Sundial common shares. The deal expands Sundial's retail footprint into liquor (Alcanna operates 171 store locations) and increases its exposure to cannabis retail through Alcanna's interest in Nova Cannabis, with expected synergies and improved cash generation.
-
Curaleaf Holdings Acquires Northern Green Canada
March 19, 2024
Pharmaceuticals
Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.
-
Curaleaf Holdings Acquires Minority Stake in Curaleaf International
July 2, 2025
Consumer Products
Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.
-
Greenlane Holdings to Acquire KushCo in All-Stock Merger
March 31, 2021
Healthcare Services
Greenlane Holdings, Inc. (NASDAQ: GNLN) and KushCo Holdings, Inc. (OTCQX: KSHB) entered into a definitive merger agreement in which KushCo will become a wholly-owned subsidiary of Greenlane. Under the terms of the deal, KushCo stockholders will receive about 0.2546 shares of Greenlane Class A common stock for each KushCo share, implying KushCo holders will own roughly 49.9% of the combined company.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.